Skip to main content
Livermore
Livermore
ZHEN

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

Holders of 5% or more of INMB

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Inmune Bio, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of INMB
HolderLatest formStakeChangeFirst filedLatest filingFiling
Highbridge Capital Management LLC13G/A5.20%1.45M shares–Aug 14, 20251 filingAug 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on Inmune Bio, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on INMB
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20254:05 PM ETHighbridge Capital Management LLC13G/A5.20%1.45M shares–Jun 30, 2025SEC
Aug 14, 20252:01 PM ETCVI Investments, Inc.and 1 other13G/A4.90%1.40M shares−0.60 ppfrom 5.50%Below 5%Jun 30, 2025SEC
Aug 14, 202512:30 PM ETPraetorian PR LLCand 5 others13G/A3.40%921.2K shares−3.80 ppfrom 7.20%Below 5%Jun 30, 2025SEC
Jul 2, 202510:09 AM ETCVI Investments, Inc.and 1 other13G5.50%1.50M sharesNewJun 27, 2025SEC
Apr 10, 202511:26 AM ETPraetorian PR LLCand 5 others13G/A7.20%1.66M shares+1.70 ppfrom 5.50%Mar 31, 2025SEC
Jan 15, 20253:41 PM ETPraetorian PR LLCand 5 others13G5.50%1.24M sharesNewJan 15, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Inmune Bio, Inc. shares.

No Form 144 notices for Inmune Bio, Inc. are on file.